Drug developers and translational scientists evaluating biomarkers in early-phase studies will learn how to leverage advanced technologies to seamlessly transform millions of data points into actionable insights.
Using advanced informatics and visualization tools, innovators can now harmonize disparate sources of biomarker data and warehouse them for more effective on-study use (e.g., dose selection, MoA, safety review meetings) and downstream use (such as interrogating data across clinical studies). Combining advanced technology with biomarker expertise provides flexibility, efficiency, and compliance. Closing the gap in translational research will result in immediate gains and mitigate risks to interim and final study deliverables.
This webinar will feature:
- Insights into biomarker data trends and challenges
- Real-world case studies
- Practical technology-based solutions that can be readily implemented